Sonora Investment Management Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.7K | Hold |
12,000
| – | – | ﹤0.01% | 299 |
|
|
2025
Q1 | $23K | Hold |
12,000
| – | – | ﹤0.01% | 300 |
|
|
2024
Q4 | $22.8K | Buy |
12,000
+2,000
| +20% | +$3.8K | ﹤0.01% | 298 |
|
|
2024
Q3 | $13.2K | Hold |
10,000
| – | – | ﹤0.01% | 288 |
|
|
2024
Q2 | $18.3K | Hold |
10,000
| – | – | ﹤0.01% | 283 |
|
|
2024
Q1 | $18.3K | Hold |
10,000
| – | – | ﹤0.01% | 284 |
|
|
2023
Q4 | $12.4K | Hold |
10,000
| – | – | ﹤0.01% | 276 |
|
|
2023
Q3 | $11.4K | Hold |
10,000
| – | – | ﹤0.01% | 265 |
|
|
2023
Q2 | $9.15K | Hold |
10,000
| – | – | ﹤0.01% | 264 |
|
|
2023
Q1 | $5.6K | Sell |
10,000
-1,085
| -10% | -$608 | ﹤0.01% | 274 |
|
|
2022
Q4 | $6.4K | Hold |
11,085
| – | – | ﹤0.01% | 268 |
|
|
2022
Q3 | $4K | Hold |
11,085
| – | – | ﹤0.01% | 209 |
|
|
2022
Q2 | $4K | Hold |
11,085
| – | – | ﹤0.01% | 246 |
|
|
2022
Q1 | $8K | Sell |
11,085
-2,000
| -15% | -$1.44K | ﹤0.01% | 225 |
|
|
2021
Q4 | $30K | Buy |
+13,085
| New | +$30K | ﹤0.01% | 213 |
|